ARCHIVES

BSA Approves Trial of Carbon Ion Therapy, Extends EDRN And Provocative Questions

This article is from The Cancer Letter archive.

Vol. 40 No. 27 | July 4, 2014

Download PDF Visit The Full Archive

Related Articles

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

December 28, 2012

DCT Board Approves Concept To Recomplete Data Management Contract

June 29, 1984

Final Money Bill Clear On Permitting New Construction Funding

December 12, 1975

HHS, NIH To Help Houston Rebuild Research Facilities.

July 13, 2001

Investigational Drug Radium-223 Chloride Improved Overall Survival By 44 Percent

September 30, 2011

Who Writes NCI’s bypass Budget anyway>? Editor’s name Revealed

May 14, 1993